Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon” or the “Company”), is a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information, and services, and sustainability industries, today announced that it priced its loan securitization.
The Horizon Funding Trust 2022-1 securitization is a private securitization under Rule 144A and to persons outside the United States pursuant to Regulation S under the Securities Act in which Horizon expects to sell a pool of loans with an aggregate principal balance of approximately $160 million to a securitization trust and receive proceeds from the issuance and sale of $100 million aggregate principal amount of 7.6878% rated notes (the “Notes”). Following pricing, total proceeds, including cash and securities, are expected to be $98.8 million before fees and expenses. A breakdown of proceeds and related descriptions are below. The offering is expected to close on November 9, 2022, subject to customary closing conditions.
The Horizon Funding Trust 2022-1 securitization transaction includes approximately $160 million in the aggregate principal balance of loans across the full credit spectrum.
Reserve Account Funding
The company expects to fund a reserve account in an amount equal to 0.75% of the principal balance as additional credit enhancement for the rated notes.
Fees and Expenses
Fees and expenses for the transaction are expected to include underwriting fees and other transaction expenses.
The transaction is scheduled to close on November 9, 2022, subject to customary closing conditions.
The notes will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from, or a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The notes were offered and are only being sold to qualified institutional buyers under Rule 144A under the Securities Act and to persons outside the United States pursuant to Regulation S under the Securities Act.
This press release is not an offer to sell, nor a solicitation of an offer to buy, any securities, nor shall there be any sale of these securities in any state or jurisdiction in which the offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.